首页> 外文期刊>The Journal of Urology >Overactive bladder medication adherence when medication is free to patients.
【24h】

Overactive bladder medication adherence when medication is free to patients.

机译:对患者免费服用药物时,膀胱过度活动药物依从性强。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: We examined overactive bladder medication compliance in a health care system in which patients do not pay for medication. MATERIALS AND METHODS: Pharmacy dispensing records were reviewed for antimuscarinic agents from January 2003 to December 2006 for the United States Military Health System National Capital Region. Medication nonpersistence, switching and adherence were examined. Kaplan-Meier survival analysis was done to compare medication persistence duration. RESULTS: Overactive bladder medications were dispensed to 7,879 adults. Tolterodine extended release (4,716 patients or 60%) and oxybutynin immediate release (2,003 or 25.5%) were most commonly prescribed. The medication nonpersistence rate, defined as the proportion of patients who never refilled a prescription for antimuscarinics during the study period, was 35.1% (2,760 of 7,858). Of 5,098 patients who refilled a prescription 1,305 changed the medication or dose at least once for a medication switch rate of 25.6%. The overall median medication possession ratio, defined as the total days of medication dispensed except for the last refill divided by the number of days between the first dispense date and the last refill date, was 0.82 in all cases. Men had a significantly higher median medication possession ratio than women (0.86 vs 0.81, p <0.001). Of patients who obtained at least 1 refill women remained on medication longer than men (median 606 vs 547 days, p = 0.01). Patients on tolterodine extended release had a higher medication nonpersistence rate than those on oxybutynin immediate release (0.89 vs 0.68, p <0.01). There was no difference between extended release medications. CONCLUSIONS: In a health care system in which patients do not pay for medications 35% of patients did not refill a prescription for overactive bladder medication, similar to previous reports. However, other measures of medication compliance were higher than those published previously in systems with copays.
机译:目的:我们在一个患者无需付费的医疗保健系统中检查了膀胱过度活动症药物的依从性。材料与方法:回顾了2003年1月至2006年12月美国军事卫生系统国家首都地区抗毒蕈碱剂的配药记录。检查了药物的非持续性,转换性和依从性。进行Kaplan-Meier生存分析以比较药物持续时间。结果:向7879名成年人分发了膀胱过度活动药物。最常见的处方是托特罗定缓释(4,716例患者,占60%)和奥昔布宁速释(2,003例,占25.5%)。药物非持续性率为35.1%(7,858中的2,760),定义为研究期间从未补充抗毒蕈碱药物处方的患者比例。在5,098例补充处方的患者中,有1,305例至少更换了一次药物或剂量一次,换药率为25.6%。在所有情况下,总体药物拥有量中位数比率(定义为最后一次补充除外的总药物分发天数除以首次分发日期与最后一次补充日期之间的天数)为0.82。男性的中位数药物拥有率明显高于女性(0.86 vs 0.81,p <0.001)。在至少获得1次补充药的患者中,女性的服药时间比男性更长(中位数606 vs 547天,p = 0.01)。托特罗定缓释患者的药物非持续性率高于奥昔布宁速释患者(0.89 vs 0.68,p <0.01)。延长释放药物之间没有差异。结论:在一个卫生保健系统中,患者不支付药物治疗费用,有35%的患者没有为膀胱过度活动症药物补充处方,类似于以前的报道。但是,其他药物依从性的衡量标准高于先前在共付额系统中发布的衡量标准。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号